Teriflunomide is an immunomodulatory disease-modifying antirheumatic drug (DMARD) used to treat multiple sclerosis and, in some contexts, rheumatoid arthritis by inhibiting dihydroorotate dehydrogenase,… Read more





![Chemical structure of (Z)-4-Amino-N,N'-bis[4-(trifluoromethyl)phenyl] benzimidamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FZ-4-Amino-NN-bis4-trifluoromethylphenyl-benzimidamide.png&w=3840&q=75)














![Chemical structure of 4-Amino-N-[4-(trifluoromethyl)phenyl]benzamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1011244-72-6-4-Amino-N-4-trifluoromethylphenylbenzamide.png&w=3840&q=75)









![Chemical structure of N-(Benzo[d][1,3]dioxol-5-ylmethyl)-2-cyanoacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F341953-72-8-N-Benzod13dioxol-5-ylmethyl-2-cyanoacetamide.png&w=3840&q=75)








Teriflunomide is an immunomodulatory disease-modifying antirheumatic drug (DMARD) used to treat multiple sclerosis and, in some contexts, rheumatoid arthritis by inhibiting dihydroorotate dehydrogenase, an enzyme involved in pyrimidine synthesis. This active metabolite of leflunomide functions by suppressing T-cell proliferation and macrophage activation. This category contains a comprehensive selection of reference standards, including impurities, metabolites, and stable isotope labelled compounds, essential for rigorous analytical testing and quality control. Pharmaceutical laboratories utilize these high-quality materials for impurity profiling, method development, and method validation to ensure the precision and reliability of assays. By providing access to pharmacopeial and non-pharmacopeial related compounds, this collection supports the critical requirements of pharmaceutical research and regulatory compliance in the analysis of teriflunomide.